A molecule family hinders spinal cord regeneration, UF brain institute team finds

GAINESVILLE---Nerve tissue transplants are among the promising experimental therapies to restore communication among cells in injured spinal cords, but scientists long have wondered why the transplanted cells don't grow more vigorously, thereby enhancing the level of recovery.

Now experiments in rats at the University of Florida Brain Institute suggest a possible explanation and a potential target for therapeutic intervention: Researchers suspect that in the days following a transplant, a particular family of molecules forms a barrier that prevents many nerve fiber connections from growing.

The molecules, chondroitin sulfate proteoglycans, or CSPGs, consist of a protein core surrounded by sugars arranged like bristles on a bottle brush; they occur naturally throughout the body. During development, CSPGs are thought to play a vital role by forming boundaries that guide migrating cells to appropriate destinations.

But following an injury, their levels increase so substantially that their growth-regulating function appears to contribute to a failure of the nerve cells to regenerate, according to research published in this month's issue of the journal Experimental Neurology.

The new study expands on previous research indicating increased levels of CSPGs following head and spinal cord injury. Unlike earlier research, however, the UF experiments involved animals with compression-type injuries, which are considered to closely mimic the damage typically experienced by people.

The UF experiments also were the first to look at CSPG expression in cellular transplants.

"We were very surprised to see that the CSPGs increased rapidly, not only in the host around the transplant, but in the transplanted tissue itself," said Dena R. Howland, a research assistant professor of neuroscience in UF's College of medicine and one of the paper's authors. "This increase appears to create a wall of molecules known to be associated with limiting growth.


Contact: Victoria White
University of Florida

Page: 1 2 3

Related biology news :

1. Small, Smac-like molecule encourages death of cancer cells
2. Tiny molecules have big potential as cancer drugs, Stanford researcher believes
3. Synthesized molecules studied as weapon to stop cell division in cancer cells
4. Scientists reinvent DNA as template to produce organic molecules
5. Sweet success in targeting sugar molecules to cells in living animals
6. Emory researchers map structure of anti-cancer molecule
7. UC Riverside researcher takes snapshots of the movement of molecules in a billionth of a second
8. Scientists pinpoint molecules that generate synapses
9. Basic RNA enzyme research promises single-molecule biosensors
10. Joslin researchers identify key molecule in Type 1 diabetes progression
11. Stem cells more vulnerable to toxic chemotherapy when protective molecule is disabled

Post Your Comments:

(Date:3/9/2019)... ... March 08, 2019 , ... Ace Laboratories, Inc. ... resveratrol + ribose hard candy lozenges ( http://www.well-mints.com ). , Well-Mints™ each contain ... hard candy base dusted with powdered sugar. , Well-Mints'™ patented technology delivers resveratrol ...
(Date:3/1/2019)... , ... February 28, 2019 , ... Teresa Krabbe, Ph.D., ... Isar of the Technical University Munich, has been awarded an xCELLigence Research Grant for ... improved oncolytic virus platform. , Oncolytic viruses represent an exciting new aspect ...
(Date:2/22/2019)... ... February 20, 2019 , ... RoosterBio, Inc, a privately held ... footprint in Frederick, MD after a year of rapid growth. , “Hundreds of ... cell (hMSCs) products to streamline their product development efforts in the regenerative medicine ...
Breaking Biology News(10 mins):
(Date:3/19/2019)... Calif. (PRWEB) , ... March 19, 2019 , ... Bogey was nine years old when ... arthritis in his left hip. These ailments caused Bogey to experience problems with his ... vehicles, up stairs, and onto his special spot on the couch. , His owners, devastated ...
(Date:3/19/2019)... ... March 19, 2019 , ... ... hospital in Israel and the Middle East region, and Swiss-based CDMO Lonza ... manufacturing platform. The partnership will enable Sheba to vastly streamline its in-house ...
(Date:3/15/2019)... ... March 15, 2019 , ... ... Inc. and affiliate companies including AVAPCO LLC and API Intellectual Properties Holdings. ... Biorefinery and R&D center in Thomaston, Georgia, operations, research, and business development ...
(Date:3/14/2019)... , ... March 14, 2019 , ... ... Conference & Expo, themed “Navigating the Full Spectrum of Case Management,” continues as ... 10-14, 2019. This conference is the only case management industry conference serving the ...
Breaking Biology Technology:
Cached News: